Clinical Trial: Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer

Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer


Sponsor and Collaborators
Duke University
Genentech
OSI Pharmaceuticals

Contact
David M Brizel, MD
919-668-5637
david.brizel@duke.edu

Clinical Trials
919-668-3726
madeline.carroll@duke.edu

Principal Investigator
David M Brizel, MD
Department of Radiation Oncology; Duke University Medical Center

Clinical Trials.gov Identifier
NCT00140556
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs